EGFR and cancer: After binding with ligands, EGFR triggers the phosphorylation of downstream pathways, such as MAPK, PI3K-AKT, JAK-STAT, and PLCγ1-PKC pathways, mainly supporting cancer cell survival and proliferation (19).